Xun Yan, Wan Wenjuan, Jiang Lu, Hu Ke
Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400000, P.R. China.
BMC Ophthalmol. 2020 Nov 16;20(1):447. doi: 10.1186/s12886-020-01694-5.
Aiming at spectacle independence, conventional pseudophakic monovision has been widely used in myopia patients with bilateral monofocal intraocular lens implantation. However, the crossed monovision, which is to correct the dominant eye for near vision and the non-dominant eye for distant vision, has been mentioned preferable for high myopic cataract patients by some studies. We have conducted this study to compare clinical results to assess the feasibility of conventional and crossed monovision for high myopic pseudophakic patients by comparing patient satisfaction, visual function and spectacle independence.
Forty-sixth high myopia patients were divided into two groups: 22 in crossed monovision group with patients whose refraction targeted to - 2.00 diopters (D) in the dominant eye and - 0.50D in the non-dominant eye; 24 in conventional monovision group with patients whose refraction targeted to - 0.50D in the dominant eye and - 2.00D in the non-dominant eye. Binocular uncorrected distance visual acuity (BUDVA), binocular uncorrected near visual acuity (BUNVA), binocular corrected distant visual acuity (BCDVA), binocular corrected near visual acuity (BCNVA), contrast visual acuity and stereoacuity were examined at postoperative 2 weeks, 1 month and 3 months. Questionnaires were completed by patients 3 months after binocular surgery to evaluate patients' satisfaction and spectacle independence.
The conventional monovision and the crossed monovision group showed no significant differences of mean BUDVA, BUNVA, BCDVA, BCNVA 2 weeks, 1 month or 3 months postoperatively (P > 0.05). There was no difference in the bilateral contrast sensitivity or stereoscopic function between the convention conventional and crossed monovision groups (P > 0.05). Patient satisfaction with near and distant vision, as well as spectacle dependence did not differ significantly between the two groups (P > 0.05).
Crossed pseudophakic monovision exhibited similar visual function when compared with conventional monovision technique, which indicates that it is an effective option to improve the visual functionality and quality of life for high myopic patients who considering bilateral cataract surgery.
The Institutional Review Board and Ethics committee of the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. The trial registration was submitted in September 2018 and passed on March 18, 2020, and the registration number is: ChiCTR2000030935 .
为了实现摆脱眼镜依赖,传统的假晶状体单眼视力矫正方法已广泛应用于接受双眼单焦点人工晶状体植入的近视患者。然而,一些研究表明,对于高度近视性白内障患者,交叉单眼视力矫正(即矫正优势眼用于近视力,非优势眼用于远视力)更为可取。我们开展了这项研究,通过比较患者满意度、视觉功能和摆脱眼镜依赖的情况,来比较传统单眼视力矫正和交叉单眼视力矫正对高度近视性假晶状体患者的临床效果,以评估其可行性。
46例高度近视患者被分为两组:22例为交叉单眼视力矫正组,优势眼的屈光度目标为-2.00屈光度(D),非优势眼为-0.50D;24例为传统单眼视力矫正组,优势眼的屈光度目标为-0.50D,非优势眼为-2.00D。在术后2周、1个月和3个月检查双眼未矫正远视力(BUDVA)、双眼未矫正近视力(BUNVA)、双眼矫正远视力(BCDVA)、双眼矫正近视力(BCNVA)、对比视力和立体视锐度。双眼手术后3个月,患者完成问卷调查,以评估患者的满意度和摆脱眼镜依赖的情况。
传统单眼视力矫正组和交叉单眼视力矫正组在术后2周、1个月或3个月时,平均BUDVA、BUNVA、BCDVA、BCNVA均无显著差异(P>0.05)。传统单眼视力矫正组和交叉单眼视力矫正组之间的双眼对比敏感度或立体视功能无差异(P>0.05)。两组患者对近视力和远视力的满意度以及对眼镜的依赖程度无显著差异(P>0.05)。
与传统单眼视力矫正技术相比,交叉假晶状体单眼视力矫正的视觉功能相似,这表明对于考虑进行双眼白内障手术的高度近视患者,交叉假晶状体单眼视力矫正是改善视觉功能和生活质量的有效选择。
中国重庆医科大学附属第一医院机构审查委员会和伦理委员会。试验注册于2018年9月提交,并于2020年3月18日通过,注册号为:ChiCTR2000030935 。